Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments. The company uses immunological insights to guide targeted protein engineering to generate transformative medicines for cancer and autoimmune disorders. GEN Edge spoke with Synthekine CEO Debanjan Ray about how the company is growing an initial set of licensed cytokine programs and platforms into a clinical-stage pipeline and proprietary combinatorial engineering platform . . .
